Cargando…

BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ

BACKGROUND: Ductal carcinoma in situ (DCIS) is considered a component of the clinical spectrum of breast cancer even in those with BRCA1/2 mutation. The aim of this study was to report the feature of DCIS raised in Japanese women with BRCA1/2 mutations. METHODS: A total of 325 Japanese women with br...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yan, Ide, Yoshimi, Inuzuka, Mayuko, Tazawa, Sakiko, Kanada, Yoko, Matsunaga, Yuki, Kuwayama, Takashi, Sawada, Terumasa, Akashi‐Tanaka, Sadako, Nakamura, Seigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418441/ https://www.ncbi.nlm.nih.gov/pubmed/30652428 http://dx.doi.org/10.1002/mgg3.493

Ejemplares similares

BRCAness as a prognostic indicator in patients with early breast cancer
por: Liu, Lei, et al.
Publicado: (2020)

The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan
por: Murakami, Wakana, et al.
Publicado: (2019)

Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X
por: Yoshida, Reiko, et al.
Publicado: (2019)

Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome
por: Kaneyasu, Tomoko, et al.
Publicado: (2020)

HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers
por: van der Groep, Petra, et al.
Publicado: (2013)

Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers
por: Faermann, Renata, et al.
Publicado: (2022)

Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast.
por: Munn, K. E., et al.
Publicado: (1996)

Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ
por: Ding, Lina, et al.
Publicado: (2019)

Ductal Carcinoma in situ Detected during Prospective MR Imaging Screening of a Woman with a BRCA2 Mutation: The First Case Report in Japan
por: Tozaki, Mitsuhiro, et al.
Publicado: (2017)

Diagnostic performance of dedicated breast positron emission tomography
por: Hashimoto, Rikako, et al.
Publicado: (2022)

Optimal Breast Density Characterization Using a Three-Dimensional Automated Breast Densitometry System
por: Yoshida, Reika, et al.
Publicado: (2021)

Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation
por: Mitchell, Gillian, et al.
Publicado: (2005)

Federated analysis of BRCA1 and BRCA2 variation in a Japanese cohort
por: Casaletto, James, et al.
Publicado: (2022)

Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2‐mutation carriers
por: Mori, Tomoharu, et al.
Publicado: (2022)

Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative
por: Elsayegh, Nisreen, et al.
Publicado: (2015)

De-novo acute myeloid leukemia in a BRCA positive female with locally treated ductal carcinoma In Situ
por: Nabrinsky, Edward, et al.
Publicado: (2021)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants
por: Momozawa, Yukihide, et al.
Publicado: (2022)

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
por: Petridis, Christos, et al.
Publicado: (2019)

Magnetically Guided Localization Using a Guiding-Marker System(®) and a Handheld Magnetic Probe for Nonpalpable Breast Lesions: A Multicenter Feasibility Study in Japan
por: Kurita, Tomoko, et al.
Publicado: (2021)

Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing
por: Hirotsu, Yosuke, et al.
Publicado: (2015)

Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma
por: Takeuchi, Shoko, et al.
Publicado: (2018)

Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
por: Wattenberg, Max M., et al.
Publicado: (2019)

Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situ
por: Tamura, Nobuko, et al.
Publicado: (2015)

Evaluation of BRCAPRO Risk Assessment Model in Patients with Ductal Carcinoma In situ Who Underwent Clinical BRCA Genetic Testing
por: Elsayegh, Nisreen, et al.
Publicado: (2016)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
por: Hart, Steven N., et al.
Publicado: (2020)

Multiplex Mutation Screening of the BRCA1 Gene in 1000 Japanese Breast Cancers
por: Emi, Mitsuru, et al.
Publicado: (1998)

Epistatic Relationships in the BRCA1-BRCA2 Pathway
por: Scully, Ralph
Publicado: (2011)

A model of the BRCA1/BRCA2 network
por: Pujana, MA, et al.
Publicado: (2005)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
por: Hatano, Yuichiro, et al.
Publicado: (2020)

Linkage Analysis of BRCA1 in Japanese Breast Cancer Families
por: Inoue, Rie, et al.
Publicado: (1994)

BRCA1 and BRCA2 mutations in Scotland and Northern Ireland
Publicado: (2003)

Clinical significance of large rearrangements in BRCA1 and BRCA2
por: Judkins, Thaddeus, et al.
Publicado: (2012)

Autoimmune response to PARP and BRCA1/BRCA2 in cancer
por: Zhu, Qing, et al.
Publicado: (2015)

The germline mutational landscape of BRCA1 and BRCA2 in Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2018)

BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis
por: Li, Qianyan, et al.
Publicado: (2021)

Prediction of carrying a BRCA1 or BRCA2 mutation
por: Lee, Kyung-Hun
Publicado: (2023)

Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma
por: Seeber, Andreas, et al.
Publicado: (2020)

Prevalence of BRCA1 and BRCA2 mutations in Japanese patients with triple-negative breast cancer: A single institute retrospective study
por: Fujisawa, Fumie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bdd0f95r9a8b2r9itgolsg2k4t